Literature DB >> 10609952

Cyclosporine-induced interstitial fibrosis and arteriolar TGF-beta expression with preserved renal blood flow.

J M Vieira1, I L Noronha, D M Malheiros, E A Burdmann.   

Abstract

BACKGROUND: Cyclosporine A (CsA)-induced chronic nephrotoxicity is characterized by interstitial fibrosis and afferent arteriole hyalinosis. CsA lesion has been linked to maintained renal vasoconstriction and narrowing of the afferent arteriole lumen diameter, leading to preglomerular ischemia. We investigated the role of renal hemodynamics in CsA-induced transforming growth factor (TGF-beta) expression and interstitial fibrosis.
METHODS: Groups of rats fed a low salt diet were given CsA 5 mg/kg/day (CsA) or the vehicle (olive oil, [VH]) s.c. and had the renal blood flow (RBF), glomerular filtration rate (GFR), mean arterial pressure, renal vascular resistance, renal histologic changes, and immunohistochemical features for macrophages and TGF-beta evaluated after 1, 2, and 8 weeks of treatment.
RESULTS: At week 1, despite normal renal hemodynamics and MAP, there was a significant macrophage interstitial influx in CsA-treated rats (70+/-16 vs. 29+/-4 cells+/0.5 mm2, in CsA vs. VH, P=0.02) that was progressive with treatment (80+/-13 vs. 32+/-8 cells+/0.5 mm2, P=0.016 and 197+/-36 vs. 23+/-3 cells+/0.5 mm2, P=0.0002, CsA vs. VH at 2 and 8 weeks, respectively). After 2 weeks of treatment, CsA animals developed a significant interstitial fibrosis, with preserved RBF, even when it was assessed 2 hr after CsA injection. There was a significant increase in the immunostaining for TGF-beta in the juxtaglomerular arterioles in CsA-treated rats (48.6+/-3.8 vs. 35.1+/-1.1%, CsA vs. VH at 2 weeks, P<0.05 and 59.0+/-3.2 vs. 37.0+/-2.1%, CsA vs. VH at 8 weeks, P=0.0001). A significant and progressive GFR decrease followed the renal structural injury of CsA treatment. Arteriolar and glomerular anatomic injury were not found throughout the study.
CONCLUSIONS: Low CsA doses might generate interstitial fibrosis without any decrease in RBF or structural arteriolar lesion evidence, possibly through early macrophage influx and increased TGF-beta expression. It clearly seems that CsA-induced ischemia and tubulointerstitial injury may occur independently, suggesting that chronic CsA nephrotoxicity may be very hard to prevent or even not be preventable at all.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10609952     DOI: 10.1097/00007890-199912150-00019

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  12 in total

1.  Cyclosporin: nephro-protective as well as nephrotoxic?

Authors:  P W Mathieson
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Annexin A1 protein attenuates cyclosporine-induced renal hemodynamics changes and macrophage infiltration in rats.

Authors:  Leandro Pires Araujo; Renata Ramos Truzzi; Gloria Elisa Florido Mendes; Marcus Alexandre Mendes Luz; Emmanuel A Burdmann; Sonia Maria Oliani
Journal:  Inflamm Res       Date:  2011-11-19       Impact factor: 4.575

3.  Down-regulation of transforming growth factor beta-2 expression is associated with the reduction of cyclosporin induced gingival overgrowth in rats treated with roxithromycin: an experimental study.

Authors:  Simone Aparecida Probst Condé; Marcus Gomes Bastos; Beatriz Julião Vieira; Fernando Monteiro Aarestrup
Journal:  BMC Oral Health       Date:  2009-12-08       Impact factor: 2.757

4.  Osteopontin expression and microvascular injury in cyclosporine nephrotoxicity.

Authors:  Beom Jin Lim; Pyung Kil Kim; Soon Won Hong; Hyeon Joo Jeong
Journal:  Pediatr Nephrol       Date:  2004-02-03       Impact factor: 3.714

5.  Influence of conversion from calcineurin inhibitors to everolimus on fibrosis, inflammation, tubular damage and vascular function in renal transplant patients.

Authors:  Nadir Alpay; Abdullah Ozkok; Yasar Caliskan; Tulin Akagun; Suzan Adın Cinar; Gunnur Deniz; Muzaffer Sariyar; Alaattin Yildiz
Journal:  Clin Exp Nephrol       Date:  2014-02-11       Impact factor: 2.801

6.  Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity?

Authors:  Anna Wasilewska; Walentyna Zoch-Zwierz; Katarzyna Taranta-Janusz; Joanna Michaluk-Skutnik
Journal:  Pediatr Nephrol       Date:  2010-05       Impact factor: 3.714

7.  Long term stabilization of expanding aortic aneurysms by a short course of cyclosporine A through transforming growth factor-beta induction.

Authors:  Jianping Dai; Stéphanie Michineau; Grégory Franck; Pascal Desgranges; Jean-Pierre Becquemin; Marianne Gervais; Eric Allaire
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

8.  Posttransplant metabolic syndrome.

Authors:  M Shadab Siddiqui; Richard K Sterling
Journal:  Int J Hepatol       Date:  2012-11-27

9.  Predictive usefulness of urinary biomarkers for the identification of cyclosporine A-induced nephrotoxicity in a rat model.

Authors:  Carla Patrícia Carlos; Nathália Martins Sonehara; Sonia Maria Oliani; Emmanuel A Burdmann
Journal:  PLoS One       Date:  2014-07-29       Impact factor: 3.240

Review 10.  Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation.

Authors:  Rita Leal; Demetra Tsapepas; Russell J Crew; Geoffrey K Dube; Lloyd Ratner; Ibrahim Batal
Journal:  Kidney Int Rep       Date:  2017-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.